BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30575108)

  • 1. IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes.
    Fang H; Reichard KK; Rabe KG; Hanson CA; Call TG; Ding W; Kenderian SS; Muchtar E; Schwager SM; Leis JF; Chanan-Khan AA; Slager SL; Braggio E; Smoley SA; Kay NE; Shanafelt TD; Van Dyke DL; Parikh SA
    Am J Hematol; 2019 Mar; 94(3):338-345. PubMed ID: 30575108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic lymphocytic leukemia patients with IGH translocations are characterized by a distinct genetic landscape with prognostic implications.
    Pérez-Carretero C; Hernández-Sánchez M; González T; Quijada-Álamo M; Martín-Izquierdo M; Hernández-Sánchez JM; Vidal MJ; de Coca AG; Aguilar C; Vargas-Pabón M; Alonso S; Sierra M; Rubio-Martínez A; Dávila J; Díaz-Valdés JR; Queizán JA; Hernández-Rivas JÁ; Benito R; Rodríguez-Vicente AE; Hernández-Rivas JM
    Int J Cancer; 2020 Nov; 147(10):2780-2792. PubMed ID: 32720348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic lymphocytic leukemia FISH panel: impact on diagnosis.
    Nelson BP; Gupta R; Dewald GW; Paternoster SF; Rosen ST; Peterson LC
    Am J Clin Pathol; 2007 Aug; 128(2):323-32. PubMed ID: 17638669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rare double-hit with two translocations involving IGH both, with BCL2 and BCL3, in a monoclonal B-cell lymphoma/leukemia.
    Alpatov R; Carstens B; Harding K; Jarrett C; Balakhani S; Lincoln J; Brzeskiewicz P; Guo Y; Ohene-Mobley A; LeRoux J; McDaniel V; Meltesen L; Minka D; Patel M; Manavi C; Swisshelm K
    Mol Cytogenet; 2015; 8():101. PubMed ID: 26719766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCL2 and BCL3 are recurrent translocation partners of the IGH locus.
    Szymanowska N; Klapper W; Gesk S; Küppers R; Martín-Subero JI; Siebert R
    Cancer Genet Cytogenet; 2008 Oct; 186(2):110-4. PubMed ID: 18940474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translocation t(14;18)/IGH-BCL2 in gastrointestinal follicular lymphoma: correlation with clinicopathologic features in 48 patients.
    Yanai S; Nakamura S; Takeshita M; Fujita K; Hirahashi M; Kawasaki K; Kurahara K; Sakai Y; Matsumoto T
    Cancer; 2011 Jun; 117(11):2467-77. PubMed ID: 24048795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia.
    Nowakowski GS; Dewald GW; Hoyer JD; Paternoster SF; Stockero KJ; Fink SR; Smoley SA; Remstein ED; Phyliky RL; Call TG; Shanafelt TD; Kay NE; Zent CS
    Br J Haematol; 2005 Jul; 130(1):36-42. PubMed ID: 15982342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotypic and cytogenetic findings of B-lymphoblastic leukemia/lymphoma associated with combined IGH/BCL2 and MYC rearrangement.
    Kelemen K; Holden J; Johnson LJ; Davion S; Robetorye RS
    Cytometry B Clin Cytom; 2017 Jul; 92(4):310-314. PubMed ID: 26517296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis.
    Cavazzini F; Hernandez JA; Gozzetti A; Russo Rossi A; De Angeli C; Tiseo R; Bardi A; Tammiso E; Crupi R; Lenoci MP; Forconi F; Lauria F; Marasca R; Maffei R; Torelli G; Gonzalez M; Martin-Jimenez P; Maria Hernandez J; Rigolin GM; Cuneo A
    Br J Haematol; 2008 Aug; 142(4):529-37. PubMed ID: 18547320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients.
    Cavazzini F; Rizzotto L; Sofritti O; Daghia G; Cibien F; Martinelli S; Ciccone M; Saccenti E; Dabusti M; Elkareem AA; Bardi A; Tammiso E; Cuneo A; Rigolin GM
    Leuk Lymphoma; 2012 Jan; 53(1):83-8. PubMed ID: 21767243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin heavy chain (IGH@) translocations negatively impact treatment-free survival for chronic lymphocytic leukemia patients who have an isolated deletion 13q abnormality.
    Gerrie AS; Bruyere H; Chan MJ; Dalal CB; Ramadan KM; Huang SJ; Toze CL; Gillan TL
    Cancer Genet; 2012 Oct; 205(10):523-7. PubMed ID: 22939229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGH Translocations in Chinese Patients With Chronic Lymphocytic Leukemia: Clinicopathologic Characteristics and Genetic Profile.
    Li Q; Xing S; Zhang H; Mao X; Xiao M; Wang Y
    Front Oncol; 2022; 12():858523. PubMed ID: 35720006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diverse B-cell tumors associated with t(14;19)(q32;q13)/IGH::BCL3 identified by G-banding and fluorescence in situ hybridization.
    Ohno H; Maekawa F; Hayashida M; Nakagawa M; Fukutsuka K; Matsumura M; Takeoka K; Maruyama W; Ukyo N; Sumiyoshi S; Tanaka Y; Haga H
    J Clin Exp Hematop; 2024; 64(1):21-31. PubMed ID: 38538317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular-cytogenetic characterization of non-Hodgkin's lymphoma with double and cryptic translocations of the immunoglobulin heavy chain gene.
    Kanda-Akano Y; Nomura K; Fujita Y; Horiike S; Nishida K; Nagai M; Miura I; Nakamura S; Seto M; Iida S; Ueda R; Taniwaki M
    Leuk Lymphoma; 2004 Aug; 45(8):1559-67. PubMed ID: 15370207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare t(X;14)(q28;q32) translocation reveals link between MTCP1 and chronic lymphocytic leukemia.
    Walker JS; Hing ZA; Sher S; Cronin J; Williams K; Harrington B; Skinner JN; Cempre CB; Gregory CT; Pan A; Yano M; Beaver LP; Walker BR; Labanowska JM; Heerema NA; Mrózek K; Woyach JA; Ruppert AS; Lehman A; Ozer HG; Coppola V; Yan P; Byrd JC; Blachly JS; Lapalombella R
    Nat Commun; 2021 Nov; 12(1):6338. PubMed ID: 34732719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splenic small B-cell lymphoma with IGH/BCL3 translocation.
    Soma LA; Gollin SM; Remstein ED; Ketterling RP; Flynn HC; Rajasenan KK; Swerdlow SH
    Hum Pathol; 2006 Feb; 37(2):218-30. PubMed ID: 16426923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent rearrangements of BCL2, BCL3, and BCL11A genes in atypical chronic lymphocytic leukemia.
    Podgornik H; Pretnar J; Skopec B; Andoljšek D; Černelč P
    Hematology; 2014 Jan; 19(1):45-8. PubMed ID: 23432949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel identification of t(14;18)(q32;q21)/IGH::MALT1 in chronic lymphocytic leukaemia.
    Kumar J; Ewalt MD; Zhang Y; Yao J; Thompson MC; Dogan A
    Br J Haematol; 2024 Feb; 204(2):561-565. PubMed ID: 38031233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward a comprehensive prognostic scoring system in chronic lymphocytic leukemia based on a combination of genetic parameters.
    Haferlach C; Dicker F; Weiss T; Schnittger S; Beck C; Grote-Metke A; Oruzio D; Kern W; Haferlach T
    Genes Chromosomes Cancer; 2010 Sep; 49(9):851-9. PubMed ID: 20552631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In non-follicular lymphoproliferative disorders, IGH/BCL2-fusion is not restricted to chronic lymphocytic leukaemia.
    Baseggio L; Geay MO; Gazzo S; Berger F; Traverse-Glehen A; Ffrench M; Hayette S; Callet-Bauchu E; Verney A; Morel D; Jallades L; Magaud JP; Salles G; Felman P
    Br J Haematol; 2012 Aug; 158(4):489-98. PubMed ID: 22686190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.